Source link : https://www.newshealth.biz/health-news/ici-tx-in-ms-patients-with-comorbid-cancer-reassuring-data/
There is no increased relapse risk in patients with multiple sclerosis (MS) and comorbid cancer who are receiving immune checkpoint inhibitor (ICI) therapy, results of a small study suggest. MS patients may be at higher risk for certain cancers, such as melanoma and lung cancer. Although ICIs have proven effective in these cancers, they have […]
Author : News Health
Publish date : 2024-04-19 14:30:22
Copyright for syndicated content belongs to the linked Source.